© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
September 27, 2021 05:00pm
This new study adds to the literature by giving the first long-term data in these populations.
September 27, 2021 04:20pm
September 27, 2021 03:06pm
September 27, 2021 03:00pm
September 27, 2021 02:36pm
Read about Amazon Pharmacy, the impact of television advertising on Marketplace insurance, and more
We interview experts on investigational treatments such as liso-cel, and ask how to bring them to community practice.
This AJMC® Profiles in Care provides an in-depth look into the results of the outcomes-based agreement between Boehringer Ingelheim and Highmark Inc.
This publication is designed for payers, formulary committees, or other similar entities with knowledge and expertise in the area of healthcare economics making decisions regarding access, coverage, and reimbursement for PEPAXTO.
If 2020 was dominated by the news of how COVID-19 spread across the globe, then 2021 has so far been focused on ending the pandemic through vaccine distribution.
View news from the ERS International Congress 2021, including session summaries, poster write-ups, and interviews with key opinion leaders
September 27, 2021
This paper utilizes latent class analysis to identify subgroups of complex conditions and of super-utilizers among health center patients to inform clinically tailored efforts.
Expert panelists discuss methods to better monitor comorbidities and adverse effects associated with Alzheimer disease.
Data-driven segmentation of high-risk patient populations may inform health system interventions, but results are dependent on the data sources and methods applied.
The authors of this editorial highlight some of the myths surrounding complex care management, identify areas where research could be most informative, and recommend best next steps in developing effective and efficient complex care management programs.
A look at the existing literature suggests more questions than answers remain when it comes to the potential use of the cholinergic anti-inflammatory pathway in connective tissue diseases (CTDs).
September 26, 2021
A recent review of viral gene therapy in pediatric neurological diseases included positive outcomes in patients with spinal muscular atrophy (SMA).
Michael E. Wechsler, MD, a pulmonologist at National Jewish Health, discusses the challenges associated with differentiating similar eosinophilic conditions, including eosinophilic asthma, from one another.
Increasing knowledge of mutations and signaling proteins in diffuse large B-cell lymphoma (DLBCL) offer prognostic and therapeutic advantages, according to a review of recent findings.
For patients with heart failure and cardiovascular disease, high intensity interval training has a greater positive effect on cardiorespiratory fitness than moderate intensity continuous training.
Immune-mediated necrotizing myopathy typically presents with progressive symmetrical proximal muscle weakness and myalgias, although some cases can present with respiratory and esophageal muscle weakness, as seen in this reported case study.